Fmoc-L-allo-Thr-OH

Fmoc-L-allo-Thr-OH is an Fmoc-protected, L-configured threonine derivative in which the side chain stereochemistry corresponds to the allo arrangement, providing a distinct chiral environment relative to the more common Thr stereoisomers. The molecule contains the Fmoc carbamate on the amino group, a free carboxylic acid for C-terminal compatibility, and a threonine side chain bearing a hydroxyl group that can participate in hydrogen bonding and can be further functionalized. The presence of the chiral center(s) in the amino acid backbone and side chain enables stereochemically defined peptide incorporation, while the Fmoc group supports standard base-labile deprotection in solid-phase or solution-phase synthesis. The combination of protected amine, free acid, and reactive side-chain hydroxyl makes the compound suitable as a chiral amino acid building block and downstream synthetic intermediate for peptide science and process-oriented amino acid derivatization.

1. Peptide Synthesis

Fmoc-L-allo-Thr-OH supports peptide building block preparation for SPPS and solution-phase coupling where a threonine residue with defined allo stereochemistry is required. The Fmoc-protected amine enables controlled N-terminal assembly, while the free carboxylic acid participates in peptide bond formation using standard coupling chemistries after activation. The side-chain hydroxyl can remain unprotected for selective transformations or be protected as needed to avoid cross-reactivity during iterative chain elongation. Incorporation of this allo-threonine analog can be applied to generate stereochemically defined peptide segments for mapping backbone/side-chain recognition, conformational effects, and coupling-site behavior in synthetic peptide libraries.

2. Side-Chain Functionalization

Fmoc-L-allo-Thr-OH enables side-chain hydroxyl derivatization strategies used in amino acid modification workflows and peptidomimetic construction. The threonine hydroxyl can be converted into protected forms for orthogonal chemistry, or transformed into leaving groups for subsequent substitution, oxidation, or conjugation steps depending on the target scaffold. The Fmoc group provides a stable handle during early functional-group manipulations, allowing sequential protection/deprotection logic that preserves stereochemical integrity at the allo-configured centers. Downstream products derived from this functionalized threonine can serve as intermediates for generating phosphorylated analogs, ether-linked motifs, or hydroxyl-bearing pharmacophore mimics used in structure-focused synthetic chemistry.

3. Unnatural Amino Acid Incorporation

Fmoc-L-allo-Thr-OH is suitable for unnatural amino acid incorporation where allo-threonine stereochemistry is used to probe stereochemical determinants in peptide and protein-like systems. The chiral allo arrangement in the side chain relative to the backbone can alter local geometry, hydrogen-bonding patterns, and steric presentation around the hydroxyl-bearing substituent. The Fmoc-protected amino group and free carboxylic acid allow integration into peptide sequences as a defined residue, enabling systematic comparison against canonical threonine analogs in combinatorial or SAR-style synthetic studies. The resulting peptides and peptide analogs can be employed as biochemical research intermediates to evaluate how stereochemistry influences binding motifs, conformational preferences, and interaction specificity without changing the overall amino acid composition.

4. Chemical Biology Labeling

Fmoc-L-allo-Thr-OH can be applied to chemical biology workflows that require stereodefined hydroxyl-containing amino acid handles for downstream conjugation. The side-chain hydroxyl enables attachment chemistries such as ether formation, linker installation, or orthogonal functional-group conversion after Fmoc removal and appropriate hydroxyl protection choices. The Fmoc group supports stepwise assembly of labeled peptide probes, including N-terminal functionalization strategies that maintain controlled orientation during conjugation. Labeled peptide intermediates derived from this compound can serve in biomolecule modification studies, affinity probe synthesis, and analytical tracer preparation where stereochemical fidelity at the allo-threonine residue matters for molecular recognition.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-allo-Thr-OH is relevant to pharmaceutical intermediate preparation for manufacturing routes that require chiral, protected amino acid building blocks with a free acid for controlled downstream conversion. The Fmoc carbamate provides a robust N-protection strategy compatible with common peptide coupling and intermediate handling, while the free carboxylic acid supports conversion into activated esters or coupling-ready derivatives in process chemistry contexts. The threonine hydroxyl can be managed through protection/deprotection logic to align with orthogonal step sequences used in fine chemical synthesis. Peptide fragments and stereodefined amino acid intermediates derived from Fmoc-L-allo-Thr-OH can feed into larger synthetic programs for peptidomimetics and peptide-based scaffolds used in applied research and industrial chemical manufacturing.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. TMEM16F and dynamins control expansive plasma membrane reservoirs